These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers. Seamonds B, Yang N, Anderson K, Whitaker B, Shaw LM, Bollinger JR. Urology; 1986 Dec; 28(6):472-9. PubMed ID: 2431533 [Abstract] [Full Text] [Related]
3. Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer. Ercole CJ, Lange PH, Mathisen M, Chiou RK, Reddy PK, Vessella RL. J Urol; 1987 Nov; 138(5):1181-4. PubMed ID: 2444720 [Abstract] [Full Text] [Related]
5. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. N Engl J Med; 1987 Oct 08; 317(15):909-16. PubMed ID: 2442609 [Abstract] [Full Text] [Related]
14. Radioimmunoassay for prostatic acid phosphatase in early prostatic carcinoma. Samuell CT, Morgans BT, O'Donoghue EP. Br J Urol; 1984 Apr 08; 56(2):208-12. PubMed ID: 6498440 [Abstract] [Full Text] [Related]
15. An evaluation of the immunochemical measurement of prostatic acid phosphatase and prostatic specific antigen in carcinoma of the prostate. Siddall JK, Cooper EH, Newling DW, Robinson MR, Whelan P. Eur Urol; 1986 Apr 08; 12(2):123-30. PubMed ID: 2420600 [Abstract] [Full Text] [Related]
17. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients. Stamey TA, Kabalin JN, Ferrari M. J Urol; 1989 May 08; 141(5):1084-7. PubMed ID: 2468796 [Abstract] [Full Text] [Related]
19. Immunoreactive prostatic acid phosphatase in prostatic cancer: diagnosis and followup of patients. Vihko P, Kontturi M, Lukkarinen O, Vihko R. J Urol; 1985 Jun 08; 133(6):979-82. PubMed ID: 3999224 [Abstract] [Full Text] [Related]